Using these selective inhibitors as a unique research tool, we show that ALDH1A3 oxidizes all-trans retinaldehyde into atRA in cancer cells that works as a paracrine factor to suppress anti-tumor T cell immunity. Here, ALDH1A3 is linked to cancer.